[1]
“TIRZEPATIDE AND RETATRUTIDE IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: CURRENT EVIDENCE AND FUTURE DIRECTIONS. A SYSTEMATIC REVIEW OF CURRENT LITERATURE”, IJITSS, vol. 1, no. 1(49), Jan. 2026, doi: 10.31435/ijitss.1(49).2026.4671.